Ansell | ANN - Sales Revenues

Stock Price
26.17
Daily Change
-0.35 -1.32%
Monthly
-6.57%
Yearly
-12.74%
Q2 Forecast
26.26

Ansell reported $1.03B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Amotiv AUD 520.5M 16.8M Dec/2025
Ansell USD 1.03B 192.2M Dec/2025
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Fisher Paykel Healthcare NZD 1.1B 21.3M Dec/2025
Healius AUD 688.1M 245.8M Dec/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 212.07M 17.03M Dec/2025
Nanosonics AUD 102.23M 2.8M Dec/2025
Polynovo AUD 70.33M 35.75M Dec/2025
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
Regis Healthcare AUD 667.75M 70.63M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Somnomed AUD 45.11M 1.46M Dec/2023
Sonic Healthcare AUD 5.45B 470M Dec/2025